Skip to content

Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety

Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety: A Pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03365375
Acronym
MBSR
Enrollment
28
Registered
2017-12-07
Start date
2018-01-28
Completion date
2020-09-01
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Chest Pain, Mindfulness

Keywords

Chest Pain, Anxiety, Mindfulness, Emergency Service, Hospital

Brief summary

This Emergency Department based study investigates the feasibility and effectiveness of a mindfulness based stress reduction (MBSR) training program referral for patients with chest pain at low risk for acute coronary syndrome but associated with anxiety. Outcomes assessed for eligible patients randomized to MBSR vs. usual care include mental health (longitudinal Generalized Anxiety Disorder - 7 (GAD-7) scores), quality of life (PROMIS Global Short Form), and ED resource utilization (return Emergency Department (ED) visits).

Detailed description

To determine the effect of an MBSR training program for patients with low-risk chest pain associated with anxiety on mental health (longitudinal GAD-7 scores, quality of life (PROMIS Global Short Form), and ED resource utilization (return ED visits). The working hypothesis is that early referral to MBSR will help patients better regulate their thoughts, feelings, and bodily sensations related to their anxiety symptoms and have a significant positive effect on patient-centered outcomes such as mental health, quality of life as well as decreased ED resource utilization. To this end the investigators will randomize patients identified via a two step process (HEART Score \<4 and GAD-7 score \> 9 to usual care referrals versus MBSR. The investigators will then follow these participants for outcomes including change in GAD-7 scores, PROMIS Global Short Form, ED utilization among other outcomes at 6 weeks, 3 months, 6 months, and 1 year.

Interventions

BEHAVIORALMBSR Referral

Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.

Referral to PCP or Psychiatry

Sponsors

Indiana University Health
CollaboratorOTHER
Indiana University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Chief complaint of chest pain * HEART Score of 0-3 indicating Major Adverse Cardiac Events (MACE) risk equivalent to ≤2% * GAD-7 score \> or = 10

Exclusion criteria

* Age \<18 or ≥ 71 * Chief complaint of anxiety, panic, or similar * Prior personal acute coronary syndrome (ACS) history (known at time of provider interview) * Previous enrollment in the study * Traumatic injury to the chest * Suicidal ideation or active psychosis or behavioral issues requiring psychiatric monitoring * Hemodynamic instability * Non-English speaking * Potential issues affecting follow up: Prisoners, homeless patients, out-of-town residences

Design outcomes

Primary

MeasureTime frameDescription
Mean Difference in Generalized Anxiety Disorder -7 (GAD-7)Measured at 3 monthsDifference in GAD-7 score at enrollment compared to assessment at 3 months. Anxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder -7Measured at 45 days, 6 months, and 12 monthsAnxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15
ED UtilizationMeasured at 45 days, 3 months, 6 months, and 12 monthsReturn visits to the Emergency Department
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Short FormMeasured at 45 days, 3 months, 6 months, and 12 monthsquality of life
Cognitive and Affective Mindfulness Scale - RevisedMeasured at 45 days, 3 months, 6 months, and 12 months12-item measure (each scored 1-4) with total of 48. A higher score is consistent with greater mindfulness qualities.
Toronto Mindfulness ScaleMeasured at 45 days, 3 months, 6 months, and 12 months13-item state-mindfulness measure that has two sub-scales: Curiosity, 6 items, subscale score ranging from 0-24, and Decentering, 7 items, with a subscale score ranging from 0-28.

Other

MeasureTime frameDescription
Patient Health Questionnaire - 8 (Depression)Measured at 45 days, 3 months, 6 months, and 12 monthsMeasure of current depression: None - Minimal depression (0 to 4), Mild depression (5 to 9), Moderate depression (10 to 14), Moderately severe depression (15 to 19), Severe depression (20 to 24)
Patient Health Questionnaire - 15 (Physical Symptoms)Measured at 45 days, 3 months, 6 months, and 12 monthsSomatic symptom severity: Minimal 0-4, Low 5-9, Medium 10-14, High 15-30
Healthcare UtilizationMeasured at 45 days, 3 months, 6 months, and 12 monthsVisits to care professionals other then the ED
PTSD ScreenerMeasured at 45 days, 3 months, 6 months, and 12 months4 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a PTSD.
Panic ScreenerMeasured at 45 days, 3 months, 6 months, and 12 months5 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a panic disorder.
Social Anxiety ScreenerMeasured at 45 days, 3 months, 6 months, and 12 months3 item measure (each scored 1-4) with total possible score of 12. Higher score associated with higher social anxiety

Countries

United States

Participant flow

Recruitment details

We screened patients who presented to the Emergency Department (ED) with chest pain. We assessed their risk for major adverse cardiac events (MACE) using the HEART score and for anxiety with the GAD-7. Enrolled subjects were assigned to either arm depending upon enrollment period. In the 8 weeks prior to the MBSR course commencement all subjects enrolled were assigned to Arm 2: MBSR. This period was immediately followed by 8 weeks of enrollment in Arm 1: Standard Referral.

Participants by arm

ArmCount
Usual Care Referral
Subjects will be referred for primary care provider (PCP) follow up and/or to psychiatry for further management and treatment of elevated anxiety levels according to standard of care.
14
MBSR Referral
MBSR Referral: Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.
14
Total28

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up04
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicUsual Care ReferralMBSR ReferralTotal
Age, Continuous43.3 years
STANDARD_DEVIATION 9.3
38.9 years
STANDARD_DEVIATION 11.9
41.2 years
STANDARD_DEVIATION 11.1
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants2 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants12 Participants25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
GAD-7 at enrollment15.9 units on a scale
STANDARD_DEVIATION 4.4
14.9 units on a scale
STANDARD_DEVIATION 3.1
15.3 units on a scale
STANDARD_DEVIATION 3.6
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
7 Participants7 Participants14 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
6 Participants5 Participants11 Participants
Sex: Female, Male
Female
11 Participants9 Participants20 Participants
Sex: Female, Male
Male
3 Participants5 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 14
other
Total, other adverse events
0 / 140 / 14
serious
Total, serious adverse events
0 / 140 / 14

Outcome results

Primary

Mean Difference in Generalized Anxiety Disorder -7 (GAD-7)

Difference in GAD-7 score at enrollment compared to assessment at 3 months. Anxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15

Time frame: Measured at 3 months

ArmMeasureValue (MEAN)Dispersion
Usual Care ReferralMean Difference in Generalized Anxiety Disorder -7 (GAD-7)5.3 score on a scaleStandard Deviation 5.4
MBSR ReferralMean Difference in Generalized Anxiety Disorder -7 (GAD-7)3.2 score on a scaleStandard Deviation 8.1
p-value: 0.82t-test, 2 sided
Secondary

Cognitive and Affective Mindfulness Scale - Revised

12-item measure (each scored 1-4) with total of 48. A higher score is consistent with greater mindfulness qualities.

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Secondary

ED Utilization

Return visits to the Emergency Department

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Secondary

Generalized Anxiety Disorder -7

Anxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15

Time frame: Measured at 45 days, 6 months, and 12 months

Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) Global Short Form

quality of life

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Secondary

Toronto Mindfulness Scale

13-item state-mindfulness measure that has two sub-scales: Curiosity, 6 items, subscale score ranging from 0-24, and Decentering, 7 items, with a subscale score ranging from 0-28.

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

Healthcare Utilization

Visits to care professionals other then the ED

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

Panic Screener

5 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a panic disorder.

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

Patient Health Questionnaire - 15 (Physical Symptoms)

Somatic symptom severity: Minimal 0-4, Low 5-9, Medium 10-14, High 15-30

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

Patient Health Questionnaire - 8 (Depression)

Measure of current depression: None - Minimal depression (0 to 4), Mild depression (5 to 9), Moderate depression (10 to 14), Moderately severe depression (15 to 19), Severe depression (20 to 24)

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

PTSD Screener

4 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a PTSD.

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Other Pre-specified

Social Anxiety Screener

3 item measure (each scored 1-4) with total possible score of 12. Higher score associated with higher social anxiety

Time frame: Measured at 45 days, 3 months, 6 months, and 12 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026